Share
10 min read
communityEvidence-based

Your blood test says 'normal.' But is it optimal for APOE4?

We built AI that shows APOE4-specific optimal ranges. Plus: see which supplement brands actually work for carriers like you.

T
· Reviewed by Dr. Kevin Tran, PharmD

Key takeaways · TL;DR

Phoenix November app update adds three APOE4-specific features: AI blood test analysis that maps biomarkers like ApoB, pTau-217, and GFAP against APOE4 optimal ranges with personalized protocols; a Smart Supplement Tracker rating 121 supplements by brand efficacy from real members; and early access to pharma trials, group-discounted medtech devices, and an upcoming vagus nerve stimulation study.

Definition

A plasma biomarker reflecting Alzheimer-related tau pathology. It correlates closely with brain amyloid and tau PET imaging.

Plasma pTau-217 has emerged as one of the most accurate blood biomarkers for Alzheimer disease and can detect pathological changes 15 to 20 years before symptoms appear.

Definition

The slow expansion of lab normal ranges as population health declines, making formerly abnormal values look acceptable.

Our November App update has just been released, and we are bringing 3 new features!

Phoenix friends,

Here's something your doctor won't tell you.
Pre-diabetic in 1995? = Normal today.
Not because we got healthier. Because the "normal range" keeps shifting.

Those reference ranges on your blood test? They're based on the 95th percentile of the general population. Which means if 95% of people are declining, the range declines with them.

You're not the general population. You're APOE4.
And "normal" isn't good enough when you're trying to prevent what's written in your genes.

But finding APOE4-specific optimal ranges? Nearly impossible. Unless your doctor specializes in APOE4 (most don't).

At The Phoenix we just fixed this problem.

Three features that change everything about how APOE4 carriers optimize their health.

I added a full demo on Youtube, the link is at the end of this post.

Feature #1: AI Blood Test Analysis & APOE4 Specific Insights

Upload any blood test.
Instead of seeing where you fall in the "normal" range, you'll see APOE4-specific optimal ranges.

Here's what you get:

Your biomarkers mapped against ranges that actually matter for APOE4 carriers. ApoB. LDL-C pTau-217. Aβ42/40 ratio. GFAP. All the markers that predict what's coming.

Bloodwork module in the Phoenix App

Then the critical part: personalized intervention protocols.

Not generic advice. Specific protocols designed to move YOUR biomarkers from where they are to where they should be.

Lower your ApoB from 85 to 60? Here's exactly how.
Optimize your inflammatory markers? Here's the protocol.

Finally, you'll know which interventions to follow based on your actual data.

Then track what actually moved the needle.
See every intervention between Blood Test A and Blood Test B on one dashboard. New supplement? Started photobiomodulation? Changed your sleep protocol?
You'll know exactly which changes drove your biomarkers up or down.

Details for each biomarkers and suggested interventions in the Phoenix App

Currently in beta. Phoenix members are testing it now.

Feature #2: Smart Supplement Tracker

Stop guessing which supplement work.
Stop wondering if your dosage is right.
Stop taking supplements because some podcast mentioned them.
Stop blindly picking supplements brands.

Long list of 121 supplements in our Phoenix app, filtered by indication

See what's actually working for APOE4 carriers like you:

  • Average efficacy scores for every supplement (from members taking them)

  • Side effect and efficacy ratings by brand (so you know which brands to take or avoid)

  • Average dosages members are taking

  • What similar carriers are taking based on your profile

    Get insights on what other APOE4 carriers similar to you are taking.

You'll see that Brand A of omega-3 has a 4.2/5 efficacy rating while Brand B sits at 2.8. You'll see that members like you take 2,000mg of resveratrol, not 500mg.

Get Insights on most popular and highest rated brands.

No more guessing.

Feature #3: Early Access to Breakthrough Therapies

Research portal inside the Phoenix App

Clinical Trial Early Access

Browse partnerships with pharmaceutical companies.
Register interest in trials. Get notified when spots open.

Next phase: Automated matching. We'll flag clinical trials you're eligible for based on your biomarkers and profile.

I am having advanced discussions with 3 pharma for partnerships coming in H1 2026 to get you the latest innovative therapies ASAP. Because we don’t have time to lose.

Group Discounts on Innovative New Medtech

Cutting-edge devices usually cost thousands.
We negotiate group discounts in exchange for anonymized efficacy data sharing.

Members get the device at cost price. Companies get real-world evidence from APOE4 carriers. We generate case studies showing what actually works. And more importantly you know if it works for YOU.

Our Neuronic study is ending tomorrow. There is still time to join, link here.

Coming in November: Vagus Nerve Stimulation Study

Similar to our Neuronic helmet study, we're launching another device trial.

This one targets your vagus nerve through auricular stimulation. Early research shows it improves sleep quality and reduces stress. But does it work well for APOE4 carriers specifically?

That's what we're testing.
More importantly: Does it work for you?

We'll share full details in a future post. But if you want early access to the study, spots are opening soon and you can register your interest on our App.

Exciting times.

Why This Matters Right Now

We are moving fast and building for APOE4 carriers around the world.
Our founding members are testing them. Giving feedback.
Helping us build something that actually works for APOE4 carriers.

And they'll never pay another dollar for any of it.

Because founding memberships lock in lifetime access.
It gives you unlimited lifetime access to everything we build in the future.
Every AI feature.
Every partnership.
Every early access to innovative therapies and medical devices.

$499 once. Forever.

But here's the thing.
AI isn't free to run. It costs us real money. Every single month. For every single member.

Take our Digital Twin AI module (coming in 2026).
It analyzes your biomarkers, genetics, environment, habits, and existing interventions to predict which protocols will actually work for you.

Not generic advice. Personalized predictions based on your data.

Estimated cost to run this for one member? ~$10 per month.
Now do the math over 20 years:

  • You invest in your health: $499 once

  • Our AI costs: $10/month = $2,400 over 20 years

  • We invest in your health: $1,900 MORE than you paid

This is how I thank you for joining the cause early on and believing in our mission to solve APOE4.

But here's what's changing.

Once our AI features go fully live, we can't keep losing money on every member.
We'll move to subscriptions.
$49/month. Or $499/year.

Founding members? You pay $499 once. Then nothing. Ever.
What You Get as a Founding Member:

Live today: 

  • Member community

  • Accountability pods with APOE4 carriers like you

  • Direct expert access

  • Supplement tracker with real efficacy data

  • APOE4-specific biomarker analysis

  • Group buying power on cutting-edge devices.

In development: 

  • Structured experiments module

  • Digital Twin AI that predicts which interventions work for you, clinical trials database

  • Early access programs with pharma partners

  • Real-world evidence partnerships.

No recurring fees. Ever.

The window is closing.

Here’s the full demo to our new features.

Kevin
Founder, Phoenix Community

Most Newsletters? One-way street.
How boring…
This is the Phoenix Community after all—so let's make it a two-way street.
Got a question? Feedback? Just want to say hi?
Hit reply.
I read every single one.

Discussion

Join the conversation

Your email will never be published. Be respectful and constructive.

FAQ

Frequently asked questions.

Why do normal lab ranges fail APOE4 carriers?
Standard reference ranges are built from the 95th percentile of the general population, so as overall health declines, the ranges drift with it. A value considered pre-diabetic in 1995 would register as normal today, not because people got healthier but because the reference band shifted. APOE4 carriers are not the general population and cannot afford average when trying to prevent what is written in their genes. Finding APOE4-specific optimal ranges is nearly impossible unless a doctor specializes in APOE4, which most do not.
Which biomarkers does the Phoenix AI Blood Test Analyzer track for APOE4?
The analyzer maps your biomarkers against APOE4-specific optimal ranges rather than generic normal bands. It covers ApoB, LDL-C, and cardiovascular lipids alongside advanced Alzheimer biomarkers including plasma pTau-217, the Abeta 42/40 ratio, and GFAP. These advanced markers are predictive of future Alzheimer pathology and increasingly available through specialty labs. The tool then generates personalized intervention protocols with specific actions to move each biomarker from where it is toward the APOE4 target.
How does the Phoenix Smart Supplement Tracker work?
The tracker holds 121 supplements filtered by indication and surfaces crowd-sourced data from Phoenix members: average efficacy scores, side effect ratings by brand, typical dosages members take, and what similar carriers with matching profiles are using. You might see that Brand A of omega-3 rates 4.2 out of 5 while Brand B sits at 2.8, or that members similar to you take 2000 mg of resveratrol rather than 500 mg. The goal is to replace guessing and podcast-driven choices with real APOE4-carrier data.
What is the Phoenix clinical trial and medtech early access program?
Phoenix partners with pharmaceutical companies and medtech manufacturers to give members early access to breakthrough therapies. Members can browse active partnerships, register interest, and get notified when trial spots open. Automated matching will eventually flag trials members are eligible for based on biomarkers and profile. Phoenix also negotiates group discounts on cutting-edge devices in exchange for anonymized efficacy data sharing, so members receive devices at cost price while companies gain real-world evidence from APOE4 carriers.
What is the upcoming Phoenix vagus nerve stimulation study?
Phoenix is launching a device trial focused on auricular vagus nerve stimulation, following the earlier Neuronic photobiomodulation helmet study. Early research suggests vagus nerve stimulation improves sleep quality and reduces stress, two levers that influence APOE4 risk through cortisol, inflammation, and glymphatic clearance. The study follows the same group-discount structure, where members contribute anonymized outcome data and receive the device at cost, generating real-world evidence on what works for APOE4 carriers.
Keep reading

Related protocols.